Gary Toedter

1.4k total citations
23 papers, 760 citations indexed

About

Gary Toedter is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Gary Toedter has authored 23 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Gary Toedter's work include HIV Research and Treatment (7 papers), Inflammatory Bowel Disease (6 papers) and HIV/AIDS drug development and treatment (6 papers). Gary Toedter is often cited by papers focused on HIV Research and Treatment (7 papers), Inflammatory Bowel Disease (6 papers) and HIV/AIDS drug development and treatment (6 papers). Gary Toedter collaborates with scholars based in United States, Belgium and Brazil. Gary Toedter's co-authors include Daniel G. Baker, Joshua F. Baker, Mary B. Leonard, William J. Harrington, Karen Hayden, Carrie Brodmerkel, Carrie Wagner, Justine Shults, Sarah Sague and Katherine Li and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Annals of Neurology.

In The Last Decade

Gary Toedter

23 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Toedter United States 14 298 187 152 138 138 23 760
Tsunefumi Shibuya Japan 17 338 1.1× 160 0.9× 107 0.7× 26 0.2× 105 0.8× 52 881
C. Gazengel France 15 255 0.9× 287 1.5× 225 1.5× 294 2.1× 69 0.5× 32 989
Patricia Baré Argentina 16 173 0.6× 228 1.2× 198 1.3× 172 1.2× 16 0.1× 46 665
Aïssatou Signaté Martinique 17 339 1.1× 209 1.1× 170 1.1× 9 0.1× 63 0.5× 47 1.1k
Marı́a M.E. de Bracco Argentina 14 289 1.0× 108 0.6× 178 1.2× 95 0.7× 33 0.2× 51 682
J L Fahey United States 7 365 1.2× 266 1.4× 266 1.8× 360 2.6× 43 0.3× 11 918
Charles R. Simrell United States 11 130 0.4× 264 1.4× 120 0.8× 111 0.8× 41 0.3× 17 764
A H Rook United States 11 623 2.1× 348 1.9× 138 0.9× 251 1.8× 66 0.5× 11 1.2k
Curtis L. Scribner United States 13 246 0.8× 302 1.6× 668 4.4× 35 0.3× 145 1.1× 22 1.4k
Angelica Beate Winter Boldt Brazil 20 691 2.3× 258 1.4× 185 1.2× 40 0.3× 72 0.5× 72 1.2k

Countries citing papers authored by Gary Toedter

Since Specialization
Citations

This map shows the geographic impact of Gary Toedter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Toedter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Toedter more than expected).

Fields of papers citing papers by Gary Toedter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Toedter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Toedter. The network helps show where Gary Toedter may publish in the future.

Co-authorship network of co-authors of Gary Toedter

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Toedter. A scholar is included among the top collaborators of Gary Toedter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Toedter. Gary Toedter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doyle, Mittie K., Mahboob U. Rahman, Bart Frederick, et al.. (2013). Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial. Lara D. Veeken. 52(7). 1214–1219. 37 indexed citations
2.
Baker, Joshua F., et al.. (2013). Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis.. PubMed. 30(5). 658–64. 59 indexed citations
3.
Baker, Joshua F., Nehal N. Mehta, Daniel G. Baker, et al.. (2012). Vitamin D, Metabolic Dyslipidemia, and Metabolic Syndrome in Rheumatoid Arthritis. The American Journal of Medicine. 125(10). 1036.e9–1036.e15. 30 indexed citations
4.
Toedter, Gary, Katherine Li, Sarah Sague, et al.. (2012). Genes Associated with Intestinal Permeability in Ulcerative Colitis: Changes in Expression Following Infliximab Therapy. Inflammatory Bowel Diseases. 18(8). 1399–1410. 38 indexed citations
5.
Toedter, Gary, Sarah Sague, Xie Wu, Michael A. Curran, & Benjamin Hsu. (2012). THU0105 Effect of sirukumab on hepcidin levels and markers of anemia: Results of a phase 2B trial in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the Rheumatic Diseases. 71. 189–190. 2 indexed citations
6.
Toedter, Gary, Katherine Li, Colleen Marano, et al.. (2011). Gene Expression Profiling and Response Signatures Associated With Differential Responses to Infliximab Treatment in Ulcerative Colitis. The American Journal of Gastroenterology. 106(7). 1272–1280. 79 indexed citations
7.
Baker, Joshua F., Michael George, Daniel G. Baker, et al.. (2011). Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis. Lara D. Veeken. 50(11). 2100–2107. 45 indexed citations
8.
9.
10.
Toedter, Gary, Marion Blank, Yinghua Lang, et al.. (2009). Relationship of C-Reactive Protein With Clinical Response After Therapy With Ustekinumab in Crohn's Disease. The American Journal of Gastroenterology. 104(11). 2768–2773. 53 indexed citations
11.
Trevino, Alex V., et al.. (1994). Effects of whole blood lysis and fixation on the infectivity of human T‐lymphotropic virus type 1 (HTLV‐I). Cytometry. 18(1). 49–54. 7 indexed citations
12.
Lairmore, Michael D., et al.. (1993). Detection of Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 2 Capsid Antigens by a Monoclonal Antibody-Based Antigen Capture Assay. AIDS Research and Human Retroviruses. 9(6). 565–571. 11 indexed citations
13.
Vasudevachari, M. B., et al.. (1993). Clinical utility of an enhanced human immunodeficiency virus type 1 p24 antigen capture assay. Journal of Clinical Immunology. 13(3). 185–192. 12 indexed citations
14.
Harrington, William J., William Sheremata, Dipak K. Dube, et al.. (1993). Spastic ataxia associated with human T‐cell lymphotrophic virus type II infection. Annals of Neurology. 33(4). 411–414. 88 indexed citations
15.
Miles, Steven A., et al.. (1993). Rapid Serologic Testing with Immune-Complex-Dissociated HIV p24 Antigen for Early Detection of HIV Infection in Neonates. New England Journal of Medicine. 328(5). 297–302. 107 indexed citations
16.
Magpantay, Larry, et al.. (1993). Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. International Journal of Gynecology & Obstetrics. 42(3). 322–323. 4 indexed citations
17.
Jackson, J. Brooks, Peter Kataaha, David L. Hom, et al.. (1993). P2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels. AIDS. 7(11). 1475–1480. 14 indexed citations
18.
Jackson, J. Brooks, Peter Kataaha, David L. Hom, et al.. (1993). Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.. PubMed. 7(11). 1475–9. 21 indexed citations
19.
Toedter, Gary, Samuel Pearlman, James R. Blakeslee, et al.. (1992). Development of a Monoclonal Antibody-Based p24 Capsid Antigen Detection Assay for HTLV-I, HTLV-II, and STLV-I Infection. AIDS Research and Human Retroviruses. 8(4). 527–532. 13 indexed citations
20.
Moore, Paul, Larry Ellingsworth, & Gary Toedter. (1986). Development and characterization of a monoclonal antibody to class II MHC antigens in rhesus macaques. Tissue Antigens. 28(2). 88–99. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsunefumi Shibuya Breakdown of academic impact, for papers by C. Gazengel Breakdown of academic impact, for papers by Patricia Baré Breakdown of academic impact, for papers by Aïssatou Signaté Breakdown of academic impact, for papers by Marı́a M.E. de Bracco Breakdown of academic impact, for papers by J L Fahey Breakdown of academic impact, for papers by Charles R. Simrell Breakdown of academic impact, for papers by A H Rook Breakdown of academic impact, for papers by Curtis L. Scribner Breakdown of academic impact, for papers by Angelica Beate Winter Boldt
Rankless by CCL
2026